*/
© Shutterstock
Casey Randall of AlphaBiolabs discusses the benefits of Non-Invasive Prenatal Paternity testing for the Family Court
Uncertainty surrounding a child’s paternity can cause significant complications in cases involving safeguarding, child maintenance, or parental responsibility, where the question of paternity can delay critical decisions, complicate care planning, and heighten tensions between parties.
While standard paternity DNA tests are now well understood and frequently used in the legal sector, many legal professionals are still not aware that paternity disputes can also be resolved before the child is born.
Thanks to developments in DNA testing, Non-Invasive Prenatal Paternity testing (NIPP) offers a safe, scientifically robust solution for determining paternity during pregnancy, with no risk to the mother or unborn child.
NIPP testing allows paternity to be established from as early as 7 weeks into pregnancy, with only a blood sample and cheek (buccal) swabs from the mother and cheek swabs from the alleged father(s) required.
Expert geneticists extract the baby’s DNA profile from foetal DNA found in the mother’s bloodstream and compare this with the DNA profile of the alleged father. The biological father will share DNA with the baby at every tested marker.
Unlike invasive forms of prenatal paternity testing which require cells to be obtained from the amniotic fluid or the placenta – carrying a small risk of miscarriage – NIPP testing is 100% risk free for mother and baby.
AlphaBiolabs’ NIPP test is the most advanced available and we are the only UK laboratory to hold UKAS 17025 accreditation for NIPP testing.
Establishing paternity during pregnancy offers clear advantages for family law professionals, social workers and local authorities involved in complex or time-sensitive family law matters.
Where paternity is in doubt, timely resolution can reduce conflict, accelerate proceedings, and ensure the welfare of the unborn child is prioritised.
NIPP testing is particularly beneficial in:
AlphaBiolabs’ NIPP testing represents the gold standard in prenatal paternity testing, analysing up to 153 DNA markers for unparalleled accuracy, and making it possible to confirm paternity from 7 weeks into pregnancy.
More reasons to choose AlphaBiolabs:
For more information, contact our New Enquiry team on 0333 600 1300/ testing@alphabiolabs.com or complete our online quote form https://www.alphabiolabs.co.uk/legal-test-forms/, and a member of the team will be happy to discuss the requirements of your case.
Uncertainty surrounding a child’s paternity can cause significant complications in cases involving safeguarding, child maintenance, or parental responsibility, where the question of paternity can delay critical decisions, complicate care planning, and heighten tensions between parties.
While standard paternity DNA tests are now well understood and frequently used in the legal sector, many legal professionals are still not aware that paternity disputes can also be resolved before the child is born.
Thanks to developments in DNA testing, Non-Invasive Prenatal Paternity testing (NIPP) offers a safe, scientifically robust solution for determining paternity during pregnancy, with no risk to the mother or unborn child.
NIPP testing allows paternity to be established from as early as 7 weeks into pregnancy, with only a blood sample and cheek (buccal) swabs from the mother and cheek swabs from the alleged father(s) required.
Expert geneticists extract the baby’s DNA profile from foetal DNA found in the mother’s bloodstream and compare this with the DNA profile of the alleged father. The biological father will share DNA with the baby at every tested marker.
Unlike invasive forms of prenatal paternity testing which require cells to be obtained from the amniotic fluid or the placenta – carrying a small risk of miscarriage – NIPP testing is 100% risk free for mother and baby.
AlphaBiolabs’ NIPP test is the most advanced available and we are the only UK laboratory to hold UKAS 17025 accreditation for NIPP testing.
Establishing paternity during pregnancy offers clear advantages for family law professionals, social workers and local authorities involved in complex or time-sensitive family law matters.
Where paternity is in doubt, timely resolution can reduce conflict, accelerate proceedings, and ensure the welfare of the unborn child is prioritised.
NIPP testing is particularly beneficial in:
AlphaBiolabs’ NIPP testing represents the gold standard in prenatal paternity testing, analysing up to 153 DNA markers for unparalleled accuracy, and making it possible to confirm paternity from 7 weeks into pregnancy.
More reasons to choose AlphaBiolabs:
For more information, contact our New Enquiry team on 0333 600 1300/ testing@alphabiolabs.com or complete our online quote form https://www.alphabiolabs.co.uk/legal-test-forms/, and a member of the team will be happy to discuss the requirements of your case.
Casey Randall of AlphaBiolabs discusses the benefits of Non-Invasive Prenatal Paternity testing for the Family Court
The Chair of the Bar reports back
Clement Cowley, Partner at The Penny Group, explains how global events can influence the performance of pensions and ISAs, and why taking a long-term approach to investing is often the most effective strategy
Mário Barroso, Head of R&D and Method Development at AlphaBiolabs, discusses what family law professionals need to know about hallucinogens, from the main hallucinogenic drugs encountered in family proceedings, to their effects and the testing options available
Harmony Christian Ministries is the latest charity to benefit from a £500 donation from AlphaBiolabs via the company’s Giving Back initiative
By David Green
Mário Barroso, Head of R&D and Method Development at AlphaBiolabs, examines the forensic science underpinning hair drug testing, its evidential scope and limitations, and why it remains the gold standard for evidencing patterns of drug use in family proceedings
Developing a tech start-up demands a different definition of excellence to the Bar, says Saara Idelbi. The co-creator of Advocatr on entrepreneurship, AI advocacy training, and matching the thrill of a killer cross-examination
At the start of her term, Chair of the Bar 2026 Kirsty Brimelow KC set out a series of priorities for the year ahead. One of those priorities was children in the justice system
As the world becomes more digital, Barbara Vinagre Mota examines international research into the mental health consequences of judges’ exposure to graphic and immersive evidence, highlighting the importance of support systems
Reviewed by Daniel Barnett
James McNeill Whistler at Tate Britain until 27 September Rothko in Florence at Palazzo Strozzi until 23 August Reviewed by Stephen Cragg KC